Now the Antiemetic You Trust is Approved For
Cats and Younger Puppies
Zoetis is excited to announce that the U.S. Food and Drug Administration (FDA) has approved two label updates for CERENIA® (maropitant citrate), the only FDA-approved veterinary antiemetic.
- CERENIA Injectable Solution is now approved for treatment of vomiting in cats 16 weeks and older
CERENIA Injectable Solution and Tablets are now recommended for the treatment and/or prevention of acute vomiting in dogs 8 weeks and older
CERENIA effectively treats vomiting from multiple causes.1 The injectable solution allows veterinarians to treat vomiting in the clinic, while the tablet formulation (for dogs) allows owners to continue therapy at home.
Important Safety Information
The safe use of CERENIA has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens. The safe use of CERENIA has not been evaluated in patients with gastrointestinal obstruction, or patients that have ingested toxins. Use with caution in patients with hepatic dysfunction. CERENIA Injectable is recommended for dogs 8 weeks and older for prevention and treatment of acute vomiting and for cats 16 weeks and older for the treatment of vomiting. CERENIA Tablets are recommended for dogs 8 weeks and older for prevention of acute vomiting and for dogs 16 weeks and older for prevention of vomiting due to motion sickness. The most common side effects seen in dogs and cats administered CERENIA are pain/vocalization (injectable), depression/lethargy, anorexia, anaphylaxis, ataxia, convulsions, and hypersalivation, and vomiting.
- Data on file, Zoetis Study Report 1467C-60-01-597. Field safety and effectiveness of subcutaneous and oral maropitant administered for emesis in dogs presented as veterinary patients.
- De la Puente-Redondo VA, Tile N, Rowan T, et al. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. AJVR 2007;68:48-56.
- Data on file, Zoetis Study Report 1960C-60-03-672. Dose confirmation of the efficacy of maropitant for apomorphine-induced emesis in dogs.
- Data on file, Zoetis Study Report 1960C-60-01-588. Dose confirmation of the efficacy of maropitant for apomorphine-induced emesis in dogs.
- De La Puente-Redondo VA, Siedek EM, Benchaoui HA, et al. The anti-emetic efficacy of maropitant (Cerenia ™) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. J Small Anim Pract 2007;48:93-98.
- Data on file, Zoetis Study Report 5961P-36-01-247. Preliminary dose selection study of maropitant administered for the prevention of emesis in dogs.
- Data on file, Zoetis Study Report 5961P-36-01-248. Preliminary study to select the dose of maropitant required for the prevention of emesis and nausea in dogs.
- Sedlacek HS, Ramsey DS, Boucher JF, et al. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. J Vet Pharm Therap 2008;31:533-537.
CERENIA is a registered trademark of Zoetis Inc. © 2012 Zoetis Inc. All rights reserved. May 2012 CER0512075